ReviewFrontiers in chemistry2026
Transition-metal-catalyzed C-S bond formation: recent developments and pharmaceutical applications.
Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to widespread applications of sulfur-containing frameworks, the construction of the C-S bond has emerged as a useful tool for synthetic organic and medicinal chemists in recent years. Transition-metal-catalyzed carbon-sulfur (C-S) bond formation represents a cornerstone of advanced organic synthesis due to its pivotal role in pharmaceuticals, agrochemicals, and functional materials. This review provides a comprehensive and structured overview of recent developments in C-S bond formation, covering both classical late transition metals (Pd, Ni, and Cu) and a broad range of miscellaneous metals (Mo, Ir, Rh, Cr, Mn, Zn, and Sc). Palladium catalysis, typically supported by phosphine or N-heterocyclic carbene ligands, enables efficient thiolation of aryl halides using thiols, disulfides, or sulfur surrogates. Nickel catalysis as a cost-effective alternative to Pd, displaying complementary reactivity toward aryl, alkyl, and heteroaryl electrophiles, often under ligand-controlled or reductive conditions, while copper follows Ullmann-type C-S couplings and oxidative thiolations using thiols, sulfinates, or elemental sulfur. Beyond these, molybdenum catalysts promote dehydrative and borrowing-hydrogen thio-etherification of alcohols, whereas iridium-based photoredox catalysis converts sodium aryl sulfinates into thioesters and thioalkynes. This review highlights the high compatibility of these methodologies with drug-like molecules and the significance of these methodologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.